Insider Transactions in Q1 2024 at Avid Bioservices, Inc. (CDMO)
Insider Transaction List (Q1 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jan 12
2024
|
Matthew R. Kwietniak Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
274
-1.36%
|
$1,644
$6.77 P/Share
|
Jan 11
2024
|
Matthew R. Kwietniak Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
669
+3.22%
|
-
|
Jan 10
2024
|
Daniel R Hart Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,408
-2.95%
|
$14,448
$6.17 P/Share
|
Jan 10
2024
|
Matthew R. Kwietniak Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,060
-5.17%
|
$6,360
$6.17 P/Share
|
Jan 10
2024
|
Richard A. Richieri Chief Operations Officer |
SELL
Open market or private sale
|
Indirect |
116
-2.18%
|
$696
$6.17 P/Share
|
Jan 10
2024
|
Richard A. Richieri Chief Operations Officer |
SELL
Open market or private sale
|
Direct |
1,055
-3.95%
|
$6,330
$6.17 P/Share
|
Jan 10
2024
|
Mark R Ziebell V. P., General Counsel |
SELL
Open market or private sale
|
Direct |
1,346
-2.08%
|
$8,076
$6.17 P/Share
|
Jan 09
2024
|
Nicholas Stewart Green President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
22,879
+3.96%
|
-
|
Jan 09
2024
|
Daniel R Hart Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,740
+2.34%
|
-
|
Jan 09
2024
|
Matthew R. Kwietniak Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,533
+6.0%
|
-
|
Jan 09
2024
|
Richard A. Richieri Chief Operations Officer |
BUY
Exercise of conversion of derivative security
|
Indirect |
255
+1.59%
|
-
|
Jan 09
2024
|
Richard A. Richieri Chief Operations Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,512
+3.13%
|
-
|
Jan 09
2024
|
Mark R Ziebell V. P., General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
3,208
+1.65%
|
-
|